Navigation Links
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
Date:11/8/2007

based primarily on two studies that enrolled chronic-phase CML patients with resistance or intolerance to Gleevec. A summary of the changes, which are detailed below, include:

-- A lower recommended starting dose of SPRYCEL 100 mg once daily based on

a dose-optimization trial - the first Phase 3 trial in this patient

population. This once daily dose was associated with a lower frequency

of some side effects (severe myelosuppression and fluid retention).

-- Cytogenetic responses from the first randomized trial of SPRYCEL, 70 mg

twice daily, and Gleevec 800 mg (400 mg twice daily), study -017. For

patients receiving SPRYCEL, at 12 weeks 36 percent achieved a major

cytogenetic response, the study's primary endpoint (29 percent with

Gleevec), and 22 percent achieved a complete cytogenetic response (8

percent with Gleevec). With longer treatment and follow-up, 52 percent

achieved a major cytogenetic response (33 percent with Gleevec), and 40

percent of patients achieved a complete cytogenetic response (16

percent with Gleevec).

The updated SPRYCEL labeling encompasses safety data for a total of 2,182 patients.

"We believe that this filing and its subsequent approval further demonstrates our commitment and dedication to patients with this disease," said Claude Nicaise, M.D., Vice President, SPRYCEL Global Development, Bristol-Myers Squibb. "Bristol-Myers Squibb is fully committed to further exploring and understanding the appropriate use of SPRYCEL through a robust clinical development program."

About the Studies

Dose-Optimization (Study -034): The Phase 3, randomized, open-label study was conducted in patients with chronic-phase CML, whose disease was resistant or intolerant to Gleevec, to evaluate the efficacy of SPRYCEL administered once daily compared with twice daily. The primary endpoint was major cytogenetic response in patients
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
3. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
4. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
7. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
10. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
11. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... and OSAKA, Japan , ... Research Application (CiRA) of Kyoto University and Takeda ... will work together to develop clinical applications of ... heart failure, diabetes mellitus, neurological disorders and cancer ... Applications" (T-CiRA) is designed to expedite multiple research ...
(Date:4/16/2015)... Francisco, CA (PRWEB) April 16, 2015 ... scheduled to report first quarter results on Thursday, April ... announcement, Cytokinetics’ senior management will host a conference call ... financial results and the company’s outlook for the future. ... can be accessed from the homepage and in the ...
(Date:4/16/2015)... April 16, 2015 Proove Biosciences ... Buzz of BIO Contest for the 2015 BIO ... the 2015 BIO International Convention will take place June ... During the Buzz of BIO contest, industry leaders will ... present at the conference. The community voting period began ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
Breaking Biology Technology:CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2
... , May 24 Newport Corporation (Nasdaq: NEWP ) today ... tomorrow, May 25, 2010 , at 3:30 pm Pacific time ... Palisades C Room of Loews Santa Monica Beach Hotel in Santa Monica, ... The 25-minute presentation by ...
... May 24 Biomedical Structures LLC (BMS), ... in advanced clinical applications from orthopedics and reconstructive surgery ... private equity financing with Ampersand Ventures. Biomedical Structures has ... an independent privately held company in 2003. Ampersand,s funding ...
... innovative family of EPA-registered disinfecting products will be launched through a new direct ... , , ... revolutionary, patented, broad-spectrum germ-killing treatment for hard surfaces.  It kills viruses, bacteria and ... approved by the EPA in 30 years. , ...
Cached Biology Technology:Newport Corporation to Present at B. Riley & Co. Investor Conference Tomorrow, May 25 2Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion 2Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion 3New Generation Disinfecting Products to be Launched in Direct Sales Channel 2
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... Wocket smart wallets is underway to early access pre-order ... group includes usage at retail outlets including Walmart, Target, ... Users report Wocket was accepted at all outlets and ...
(Date:3/26/2015)... 2015 The Granite Club, ... athletic club, today announced it has implemented a state-of-the-art ... movement for members and staff, while restricting access to ... we selected FST,s IMID Access system because it has ... members and staff, in addition to unparalleled security," said ...
(Date:3/23/2015)... BOSTON, Mass , March 23, 2015 SoundView ... shipment of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView ... world user feedback on their experience with the Wocket in ... experience at CVS, Whole Foods and other retailers, making both ... Kris Tuttle also says, "If the company meets ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... bone field are to be featured speakers and session ... Osteoarthritis (IOF-ECCEO12). As the major European bone event of ... clinical advances in the bone field. The meeting ... Osteoporosis Foundation (IOF) and the European Society for Clinical ...
... Helmholtz Zentrum Munich and LMU Munich, in cooperation ... London (KCL), have identified several associations between genetic ... today in Nature, provides new functional ... development of complex common diseases. In the ...
... pikas, the chirpy, potato-sized denizens of rocky debris in mountain ... their own in the Southern Rocky Mountains, says a new ... student Liesl Erb, the study team assessed 69 historical sites ... Rockies ranging from southern Wyoming through Colorado and into northern ...
Cached Biology News:European Congress on Osteoporosis & Osteoarthritis opens online registration 2Genetics meets metabolomics 2Southern Rocky Mountain pikas holding their own, says new CU-Boulder assessment 2Southern Rocky Mountain pikas holding their own, says new CU-Boulder assessment 3Southern Rocky Mountain pikas holding their own, says new CU-Boulder assessment 4
... pleased to offer the ATTO-TAG series ... of primary amines. Developed by Novotny ... ATTO-TAG reagents are similar to the ... and anthracene-2,3-dicarboxaldehyde, all of which are ...
Anti-SDF-1β/PBSF affinity isolated antibody lyophilized powder Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline recombinant human SDF-1β/PBSF expressed in E....
... freezers , Ultima II Series ... storage, Ultima II represents the finest, most ... purpose and blood bank configurations, each Ultima ... control system with built-in voltage boost and ...
... Software is the ultimate tool for ... handling. There are two editions of ... for scientists working in life science ... offering features needed for compliance with ...
Biology Products: